FOXO Shareholder News: Johnson Fistula Encouraged

FOXO Shareholder News: Johnson Fistula Encouraged


SAN DIEGO, Nov. 15, 2022 (GLOBE NEWSWIRE) — The shareholder rights law firm Johnson Fistel, LLP ( is investigating FOXO Technologies Inc. (“FOXO” or the “Company”) (NYSE_AM: FOXO), any of its officers or others who have violated securities laws by misrepresenting or not timely providing material, adverse information to investors have disclosed. The investigation focuses on investors’ losses and whether they can be recovered under federal securities laws.

What if I bought FOXO common stock? If you bought FOXO common stock and suffered significant losses on your investment, join our investigation now:

Copy and paste the following web address into your browser to submit your losses:

Or contact Jim Baker at for more information [email protected] or (619) 814-4471

There are no costs or obligations for you.

What does Johnson examine fistula? On February 24, 2022, FOXO entered into a definitive merger agreement with special purpose vehicle Delwinds Insurance Acquisition Corp. (“Delwinds”) (NYSE: DWIN).

On September 15, 2022, FOXO launched its IPO (initial public offering) via a reverse merger with a special purpose entity (SPAC), Delwinds. The stock opened trading at $7.29.

On November 14, 2022, FOXO Technologies will reschedule its third quarter 2022 earnings report and conference call.

On November 14, 2022, FOXO Technologies announces the departure of Chief Product Officer Erin Sharoni.

On November 14, 2022, FOXO stock closed at $0.5651.

What if I have relevant non-public information? Those with nonpublic information about the company should consider cooperating with our investigation or participating in the SEC’s whistleblower program. Under the SEC program, whistleblowers who provide original information can, under certain circumstances, receive rewards of up to thirty percent of all successful…

Continue to read on GlobeNewswire

More to explorer